SCHEMBL903893

SCHEMBL903893

CS(=O)(=O)N1CCN(Cc2ccc(O)c(F)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
KDM4E B2RXH2 3/20 0.54
LMNA P02545 1/20 0.48
KCNH2 Q12809 1/20 0.46
MCHR1 Q99705 1/20 0.46
ICAM1 P05362 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RECQL P46063 1/20 0.44
ACHE P22303 1/20 0.43
CCR3 P51677 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068063 0.89 ALDH1A1 (0.43) ALDH1A1KDM4ELMNAKCNH2MCHR1
SCHEMBL904202 0.84 ALDH1A1 (0.51) ALDH1A1KDM4ELMNANPSR1HTT
SCHEMBL903886 0.83 KDM4E (0.54) ALDH1A1KDM4ELMNASMN1; SMN2RECQL
SCHEMBL904002 0.83 KDM4E (0.51) ALDH1A1KDM4ELMNAICAM1SMN1; SMN2
SCHEMBL1003970 0.83 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAKCNH2MCHR1
SCHEMBL15495062 0.81 CHKA (0.58) ALDH1A1KDM4ELMNAHTT
SCHEMBL1006389 0.80 KDM4E (0.54) ALDH1A1KDM4ELMNASMN1; SMN2CCR3
SCHEMBL940416 0.79 ALDH1A1 (0.62) ALDH1A1KDM4ENPSR1SMN1; SMN2RECQL
SCHEMBL1005879 0.79 KDM4E (0.62) ALDH1A1KDM4ELMNANPSR1SMN1; SMN2
SCHEMBL4694589 0.77 ALDH1A1 (0.72) ALDH1A1KDM4EHTTSMN1; SMN2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102432598-A Tricyclic compound, preparation method thereof and pharmaceutical application thereof JIANGSU HENGRUI MEDICINE CO 2012-05-02 CN disclosed
WO-2012041158-A1 TRICYCLIC COMPOUND, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-04-05 WO disclosed